Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Aguora Hills, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Oncotelic Therapeutics, Inc. has filed 1,204 SEC EDGAR filings since 04 Apr 1996

SEC filing history

Showing 701-725 of 770 matching filings.

Per page
25
Current page
29
CORRESP

CORRESP filing

Filing date
15 Oct 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K FILING DOCUMENT

Filing date
12 Oct 2010
Reporting date
11 Oct 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-150595

424B3

Filing date
23 Sep 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Sep 2010
Reporting date
15 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Sep 2010
Reporting date
15 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Sep 2010
Reporting date
15 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

AMENDMENT TO FORM 4

Filing date
15 Sep 2010
Reporting date
01 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K FILING DOCUMENT

Filing date
13 Sep 2010
Reporting date
12 Sep 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
31 Aug 2010
Reporting date
30 Aug 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
23 Aug 2010
Reporting date
20 Aug 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-150595

OXIGENE, INC.

Filing date
17 Aug 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 000-21990

FORM 10-Q

Filing date
13 Aug 2010
Reporting date
30 Jun 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
13 Aug 2010
Reporting date
12 Aug 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 Aug 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
05 Aug 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
23 Jul 2010
Reporting date
21 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-155371

424B5

Filing date
22 Jul 2010
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

OXIGENE, INC.

Filing date
21 Jul 2010
Reporting date
21 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jul 2010
Reporting date
01 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jul 2010
Reporting date
01 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jul 2010
Reporting date
01 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jul 2010
Reporting date
01 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jul 2010
Reporting date
01 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
06 Jul 2010
Reporting date
01 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21990

FORM 8-K

Filing date
01 Jul 2010
Reporting date
01 Jul 2010
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .